23.1 C
New York

3i in exclusive negotiation to exit Havea Group at big boost to valuation


3i has entered into an exclusive negotiation to exit Havea Group to BC Partners at a valuation 50% higher than when it bought into the business.

Havea provides natural healthcare under five brands including Aragan, Biolane, Densmore, Dermovitamina and Vitavea.

3i bought into Havea in 2017. The firm said the company has doubled in size during the time, reaching €212m sales in 2021. It has also delivered double-digit organic growth and completed five acquisitions in five years.

Rémi Carnimolla, partner and managing director at 3i, said “The thesis supporting our investment in Havea was to back the global megatrend towards more natural and sustainable healthcare products. Havea benefits from this thanks to its strong innovation culture and willingness to constantly improve and understand the consumer journey.

“Havea’s tremendous development was made possible by Nicolas and his team. We are proud to have partnered with them; their agility and fantastic entrepreneurial culture will lead them to even greater successes.”

UK- headquartered 3i Group has made six promotions to partner in its private equity team two months ago.

The firm agreed  to back Dutch food and drink container brand Mepal in November as it looks to grow the business across Europe and scored a 2.6x return by selling Magnitude Software to trade buyer Insightsoftware for £344m last year.

Copyright © 2022 AltAssets

  • Coinsmart. Europe’s Best Bitcoin and Crypto Exchange.Click Here
  • Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
  • Source: https://www.altassets.net/private-equity-news/by-news-type/deal-news/3i-in-exclusive-negotiation-to-exit-havea-group-after-50-valuation-growth.html

This Post was originally published on Altassets

Related articles


Recent articles